XML 37 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Net Revenues        
Asset management and administration fees $ 649 $ 583 $ 1,892 $ 1,707
Interest revenue 600 531 1,767 1,527
Interest expense (27) (25) (79) (79)
Net interest revenue 573 506 1,688 1,448
Trading revenue 209 224 668 682
Other 120 57 253 172
Provision for loan losses 1 4 7 (1)
Net impairment losses on securities (1) [1] (1) [1] (1) [1] (8) [1]
Total net revenues 1,551 1,373 4,507 4,000
Expenses Excluding Interest        
Compensation and benefits 593 482 1,641 1,512
Professional services 117 103 335 308
Occupancy and equipment 82 77 242 231
Advertising and market development 59 57 187 198
Communications 55 55 168 165
Depreciation and amortization 49 51 145 153
Other 78 84 228 226
Total expenses excluding interest 1,033 909 2,946 2,793
Income before taxes on income 518 464 1,561 1,207
Taxes on income 197 174 590 455
Net Income 321 290 971 752
Preferred stock dividends 9 8 39 39
Net Income Available to Common Stockholders $ 312 $ 282 $ 932 $ 713
Weighted-Average Common Shares Outstanding - Diluted 1,316 [2] 1,296 [2] 1,313 [2] 1,288 [2]
Earnings Per Common Share - Basic $ 0.24 $ 0.22 $ 0.71 $ 0.55
Earnings Per Common Share - Diluted $ 0.24 $ 0.22 $ 0.70 $ 0.55
[1] Net impairment losses on securities include total other-than-temporary impairment losses of $1 million and $0 recognized in other comprehensive income, net of $0 and $(1) million reclassified from other comprehensive income, for the three months ended September 30, 2014 and 2013, respectively. Net impairment losses on securities include total other-than-temporary impairment losses of $1 million and $2 million recognized in other comprehensive income, net of $0 and $(6) million reclassified from other comprehensive income, for the nine months ended September 30, 2014 and 2013, respectively.
[2] Antidilutive stock options and restricted stock awards excluded from the calculation of diluted EPS totaled 12 million and 19 million shares for the third quarters of 2014 and 2013, respectively, and 18 million and 31 million shares for the first nine months of 2014 and 2013, respectively.